This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schaeffer, L. M. Articles by Weiss, A. A. Search for Related Content PubMed PubMed Citation Articles by Schaeffer, L. M. Articles by Weiss, A. A.

 Previous Article  |  Next Article 

Infection and Immunity, December 2004, p. 7124-7130, Vol. 72, No. 12
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.12.7124-7130.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Interactions of Pulmonary Collectins with Bordetella bronchiseptica and Bordetella pertussis Lipopolysaccharide Elucidate the Structural Basis of Their Antimicrobial Activities

Department of Molecular Genetics, Biochemistry, and Microbiology,¹ Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Cincinnati, Cincinnati, Ohio²

Received 29 April 2004/ Returned for modification 28 June 2004/ Accepted 9 August 2004

Surfactant proteins A (SP-A) and D (SP-D) play an important role in the innate immune defenses of the respiratory tract. SP-A binds to the lipid A region of lipopolysaccharide (LPS), and SP-D binds to the core oligosaccharide region. Both proteins induce aggregation, act as opsonins for neutrophils and macrophages, and have direct antimicrobial activity. Bordetella pertussis LPS has a branched core structure and a nonrepeating terminal trisaccharide. Bordetella bronchiseptica LPS has the same structure, but lipid A is palmitoylated and there is a repeating O-antigen polysaccharide. The ability of SP-A and SP-D to agglutinate and permeabilize wild-type and LPS mutants of B. pertussis and B. bronchiseptica was examined. Previously, wild-type B. pertussis was shown to resist the effects of SP-A; however, LPS mutants lacking the terminal trisaccharide were susceptible to SP-A. In this study, SP-A was found to aggregate and permeabilize a B. bronchiseptica mutant lacking the terminal trisaccharide, while wild-type B. bronchiseptica and mutants lacking only the palmitoyl transferase or O antigen were resistant to SP-A. Wild-type B. pertussis and B. bronchiseptica were both resistant to SP-D; however, LPS mutants of either strain lacking the terminal trisaccharide were aggregated and permeabilized by SP-D. We conclude that the terminal trisaccharide protects Bordetella species from the bactericidal functions of SP-A and SP-D. The O antigen and palmitoylated lipid A of B. bronchiseptica play no role in this resistance.

Editor: J. T. Barbieri

This article has been cited by other articles:

• Canadas, O., Garcia-Verdugo, I., Keough, K. M. W., Casals, C. (2008). SP-A Permeabilizes Lipopolysaccharide Membranes by Forming Protein Aggregates that Extract Lipids from the Membrane. Biophys. J 95: 3287-3294 [Abstract] [Full Text]  
• Fedele, G., Nasso, M., Spensieri, F., Palazzo, R., Frasca, L., Watanabe, M., Ausiello, C. M. (2008). Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis Differently Modulate Human Dendritic Cell Functions Resulting in Divergent Prevalence of Th17-Polarized Responses. J. Immunol. 181: 208-216 [Abstract] [Full Text]  
• Elahi, S., Buchanan, R. M., Attah-Poku, S., Townsend, H. G. G., Babiuk, L. A., Gerdts, V. (2006). The Host Defense Peptide Beta-Defensin 1 Confers Protection against Bordetella pertussis in Newborn Piglets. Infect. Immun. 74: 2338-2352 [Abstract] [Full Text]